A VAMP-binding protein from Aplysia required for neurotransmitter release
about
Intrinsically unstructured domain 3 of hepatitis C Virus NS5A forms a "fuzzy complex" with VAPB-MSP domain which carries ALS-causing mutationsThe proximal signaling network of the BCR-ABL1 oncogene shows a modular organizationElectrostatic interaction between oxysterol-binding protein and VAMP-associated protein A revealed by NMR and mutagenesis studiesA mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis.Identification of a human homologue of the vesicle-associated membrane protein (VAMP)-associated protein of 33 kDa (VAP-33): a broadly expressed protein that binds to VAMPFFAT rescues VAPA-mediated inhibition of ER-to-Golgi transport and VAPB-mediated ER aggregationHuman VAP-C negatively regulates hepatitis C virus propagationHuman VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5BA conserved ER targeting motif in three families of lipid binding proteins and in Opi1p binds VAPA Drosophila model of ALS: human ALS-associated mutation in VAP33A suggests a dominant negative mechanismA VAMP-associated protein, PVA31 is involved in leaf senescence in Arabidopsis.The Saccharomyces cerevisiae suppressor of choline sensitivity (SCS2) gene is a multicopy Suppressor of mec1 telomeric silencing defectsThe Saccharomyces cerevisiae SCS2 gene product, a homolog of a synaptobrevin-associated protein, is an integral membrane protein of the endoplasmic reticulum and is required for inositol metabolism.Inheritance of cortical ER in yeast is required for normal septin organization.Protrudin serves as an adaptor molecule that connects KIF5 and its cargoes in vesicular transport during process formationStructural, stability, dynamic and binding properties of the ALS-causing T46I mutant of the hVAPB MSP domain as revealed by NMR and MD simulationsMouse VAP33 is associated with the endoplasmic reticulum and microtubulesC-Terminal Auto-Regulatory Motif of Hepatitis C Virus NS5B Interacts with Human VAPB-MSP to Form a Dynamic Replication ComplexVAPC, an human endogenous inhibitor for hepatitis C virus (HCV) infection, is intrinsically unstructured but forms a "fuzzy complex" with HCV NS5B.Phosphatidylserine synthesis at membrane contact sites promotes its transport out of the ER.Interaction between the motor protein prestin and the transporter protein VAPAGlobal gene expression analysis of the shoot apical meristem of maize (Zea mays L.).Protein phosphatase 2Cepsilon is an endoplasmic reticulum integral membrane protein that dephosphorylates the ceramide transport protein CERT to enhance its association with organelle membranes.VAPB/ALS8 interacts with FFAT-like proteins including the p97 cofactor FAF1 and the ASNA1 ATPaseThe C. elegans VAPB homolog VPR-1 is a permissive signal for gonad development.Molecular physiology and pathophysiology of tight junctions I. Tight junction structure and function: lessons from mutant animals and proteins.A Trypanosoma brucei protein required for maintenance of the flagellum attachment zone and flagellar pocket ER domains.Vesicle-associated membrane protein-associated protein-A (VAP-A) interacts with the oxysterol-binding protein to modify export from the endoplasmic reticulum.Analysis of the key elements of FFAT-like motifs identifies new proteins that potentially bind VAP on the ER, including two AKAPs and FAPP2.VAMP-associated protein B (VAPB) promotes breast tumor growth by modulation of Akt activity.A genetic screen identifies Tor as an interactor of VAPB in a Drosophila model of amyotrophic lateral sclerosis.The diverse functions of oxysterol-binding proteinsDISC1 regulates synaptic vesicle transport via a lithium-sensitive pathway.What is the role of SNARE proteins in membrane fusion?An Eph receptor sperm-sensing control mechanism for oocyte meiotic maturation in Caenorhabditis elegans.ERG30, a VAP-33-related protein, functions in protein transport mediated by COPI vesicleshVAPB, the causative gene of a heterogeneous group of motor neuron diseases in humans, is functionally interchangeable with its Drosophila homologue DVAP-33A at the neuromuscular junction.Widespread aggregation of mutant VAPB associated with ALS does not cause motor neuron degeneration or modulate mutant SOD1 aggregation and toxicity in mice.A Role for MOSPD1 in Mesenchymal Stem Cell Proliferation and Differentiation.VAMP-associated Proteins (VAP) as Receptors That Couple Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Proteostasis with Lipid Homeostasis.
P2860
Q21560973-42C8CBA5-103E-4DD8-8AF0-A8B83ECEC743Q24294830-ED48A562-30BC-433A-8C0F-026E1307A4B6Q24300745-E99E4FAB-03F7-410D-8F9B-9C1850BAC9D0Q24304337-FB260261-C960-4729-85D8-EABE57F2CF7CQ24313250-B574A27B-829B-4CED-8FCF-312313AB53DAQ24324427-903E34A1-95A7-4C22-9FB8-4E639EAA164AQ24337683-2D3EBC36-53A9-46F2-9A7C-9EE9681CB9F4Q24338324-9D56A0F1-A8B3-482F-B599-0FF889AE863AQ24675994-36C782E8-D200-433E-B8AF-6ADE86BDE21EQ27301268-D18E9C6C-7345-42D3-A92A-A741D6930E0AQ27302023-41B5B6CC-3FDE-48A6-9536-31AEB58AB352Q27929956-64ADBD0A-D9F0-465D-8580-A8467902E087Q27939537-2E0D2713-6A46-43F6-A0E7-11460C88D647Q27940243-80F99DF6-B1F3-444C-876A-D238EB4D34F1Q28115614-309E9758-74F8-4A38-8AC9-409F18DF5302Q28477745-8C6A6EC5-0B98-48D5-A804-44BB753B98CFQ28506611-065779B3-8E76-49AF-9952-21D67EA28E6AQ28552592-9BE49976-9D56-4210-892C-A4D163B9AEE3Q30155273-9F1A4C73-045C-4C41-BAC3-631A2E6CD243Q30274928-25C2C7F0-3363-4DC4-92DE-4176062BAB28Q30494739-515E9A73-F89D-4811-8813-3F1244ECC1C6Q33296298-0DEB6ABC-DCA3-4518-88B2-0E614B64A812Q33312802-28ED56EC-D554-4405-A06B-7939C8340A89Q33797100-26494B90-6366-4936-B1B2-2221B171C4F9Q33830458-35B8DCC9-573B-4C74-A7B3-A1BE138EA5FFQ33984204-0C034485-A774-4C79-B87C-5C49BEAF4568Q34107101-46D6B114-BAC1-4142-B4F5-C8A0A9152D13Q34129670-D0D949F3-7FE7-4A61-A717-03068A414123Q34140627-6860FA49-294A-4584-96E6-5F74553CC66BQ34437633-099D977A-5024-47D3-8F24-2BD0CDC7A3E3Q34515862-3CF7B00A-9104-483C-B2C6-76F7AEB1717FQ34990521-D0C81092-366B-4F65-9748-ED88F74EC963Q35164530-47FEE9B8-8432-4E77-8394-12D2FC032661Q35169800-06B68184-6D31-429C-9607-87A999FEEBAEQ35963706-43779A20-4595-45D0-A109-FA55608F165DQ36301570-98EDB90A-F5C0-49F9-A781-F0129B6C2E9FQ36451026-2C06C423-0412-4097-8158-7E7ED532AD55Q36513305-DE6AC76F-B00D-4407-B262-D229D8808646Q36532559-3EB7FEA4-4D90-4054-BC27-4ED99CAB108AQ36650360-241AFD09-9F1A-4A70-9C89-D2582E587633
P2860
A VAMP-binding protein from Aplysia required for neurotransmitter release
description
1995 nî lūn-bûn
@nan
1995 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
A VAMP-binding protein from Aplysia required for neurotransmitter release
@ast
A VAMP-binding protein from Aplysia required for neurotransmitter release
@en
A VAMP-binding protein from Aplysia required for neurotransmitter release
@nl
type
label
A VAMP-binding protein from Aplysia required for neurotransmitter release
@ast
A VAMP-binding protein from Aplysia required for neurotransmitter release
@en
A VAMP-binding protein from Aplysia required for neurotransmitter release
@nl
prefLabel
A VAMP-binding protein from Aplysia required for neurotransmitter release
@ast
A VAMP-binding protein from Aplysia required for neurotransmitter release
@en
A VAMP-binding protein from Aplysia required for neurotransmitter release
@nl
P2093
P356
P1433
P1476
A VAMP-binding protein from Aplysia required for neurotransmitter release
@en
P2093
E R Kandel
K C Martin
P A Skehel
P304
P356
10.1126/SCIENCE.7667638
P407
P577
1995-09-15T00:00:00Z